Tuesday, February 05, 2019 8:42:55 AM
Biotech stocks hitting 52-week highs on Feb. 4
Axsome Therapeutics Inc (NASDAQ: AXSM)
AEterna Zentaris Inc. (NASDAQ: AEZS)
BioSpecifics Technologies Corp. (NASDAQ: BSTC)
Dr.Reddy's Laboratories Ltd (NYSE: RDY)(reacted to Dec. quarter results)
Eli Lilly And Co (NYSE: LLY)
Medpace Holdings Inc (NASDAQ: MEDP)
Osiris Therapeutics, Inc. (NASDAQ: OSIR)
Veracyte Inc (NASDAQ: VCYT)
XBiotech Inc (NASDAQ: XBIT)
Axsome Therapeutics Inc (NASDAQ: AXSM)
AEterna Zentaris Inc. (NASDAQ: AEZS)
BioSpecifics Technologies Corp. (NASDAQ: BSTC)
Dr.Reddy's Laboratories Ltd (NYSE: RDY)(reacted to Dec. quarter results)
Eli Lilly And Co (NYSE: LLY)
Medpace Holdings Inc (NASDAQ: MEDP)
Osiris Therapeutics, Inc. (NASDAQ: OSIR)
Veracyte Inc (NASDAQ: VCYT)
XBiotech Inc (NASDAQ: XBIT)
All posts are speculative and my opinion only. NOT investment advice.
Recent AXSM News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 11:05:09 AM
- Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions • GlobeNewswire Inc. • 04/01/2026 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 03/26/2026 08:11:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2026 12:10:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2026 12:10:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2026 12:10:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2026 12:10:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2026 12:00:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2026 12:00:06 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2026 09:53:07 PM
- Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders • PR Newswire (Canada) • 02/26/2026 05:07:00 PM
- Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders • PR Newswire (US) • 02/26/2026 05:07:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 12:00:03 AM
- Axsome Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms • GlobeNewswire Inc. • 02/24/2026 12:00:00 PM
- Axsome Shares Slip Despite Fourth-Quarter Earnings Beat and Strong Revenue Growth • IH Market News • 02/23/2026 04:11:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 12:18:03 PM
- Axsome Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/23/2026 12:00:00 PM
- Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/18/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 12:05:46 PM
- Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Alkem Laboratories Ltd. • GlobeNewswire Inc. • 02/17/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 12:11:27 AM
- Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 23 • GlobeNewswire Inc. • 01/27/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2026 12:00:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2026 12:00:03 AM
